Latest Breaking News On - Ligand pharmaceuticals trading - Page 1 : vimarsana.com

Ligand Pharmaceuticals (NASDAQ:LGND) Releases Earnings Results, Beats Expectations By $3 01 EPS

Ligand Pharmaceuticals (NASDAQ:LGND) Releases Earnings Results, Beats Expectations By $3 01 EPS
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Stephenl sabbaEarnings history for ligand pharmaceuticalsNews ratings for ligand pharmaceuticals dailyLigand pharmaceuticals tradingLigand pharmaceuticals incorporatedSecurities exchange commissionLigand pharmaceuticalsLigand pharmaceuticals company profileGet free reportDirector stephenExchange commissionPharmaceuticals incorporatedLigand pharmaceuticals daily

HC Wainwright Reaffirms Buy Rating for Ligand Pharmaceuticals (NASDAQ:LGND)

HC Wainwright Reaffirms Buy Rating for Ligand Pharmaceuticals (NASDAQ:LGND)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Stephenl sabbaLigand pharmaceuticals incorporatedNews ratings for ligand pharmaceuticals dailyLigand pharmaceuticals tradingLigand pharmaceuticalsPacer advisors incChina universal asset management coDeutsche bankAllspring global investments holdingsImpax asset management groupGet free reportDirector stephenAsset management groupGlobal investments holdingsUniversal asset managementPharmaceuticals incorporated

Summit Global Investments Sells 2,685 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)

Summit Global Investments Sells 2,685 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Stephenl sabbaRussell investments group ltdFisher asset managementQuarter for ligand pharmaceuticalsCetera trust companyLigand pharmaceuticals tradingExchange commissionVictory capital management incLigand pharmaceuticalsLigand pharmaceuticals incorporatedNews ratings for ligand pharmaceuticals dailyAcuitas investmentsSummit global investmentsFree reportGlobal investmentsAsset management

Ligand Pharmaceuticals (LGND) Set to Announce Earnings on Tuesday

Ligand Pharmaceuticals (NASDAQ:LGND – Get Free Report) is scheduled to be posting its quarterly earnings results after the market closes on Tuesday, May 7th. Analysts expect Ligand Pharmaceuticals to post earnings of $1.13 per share for the quarter. Ligand Pharmaceuticals has set its FY 2024 guidance at 4.250-4.750 EPS and its FY24 guidance at $4.25 […]

Stephenl sabbaLigand pharmaceuticalsLigand pharmaceuticals tradingEarnings history for ligand pharmaceuticalsLigand pharmaceuticals incorporatedInsider activity at ligand pharmaceuticalsNews ratings for ligand pharmaceuticals dailySecurities exchange commissionGet free reportDirector stephenExchange commissionPharmaceuticals incorporatedLigand pharmaceuticals dailyNasdaq lgnd

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives $109 75 Average Target Price from Analysts

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives $109 75 Average Target Price from Analysts
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Toddc davisLigand pharmaceuticals incorporatedMetlife investment managementYousif capital managementInstitutional investors weigh in on ligand pharmaceuticalsNews ratings for ligand pharmaceuticals dailyDimensional fund advisorsLigand pharmaceuticalsLigand pharmaceuticals tradingAdvisor group holdings incGet free reportMarketbeat ratingsGroup holdingsLife investment managementCapital managementFund advisors